Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05627063
Title A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Abbisko Therapeutics Co, Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Comprehensive Cancer Centers of Nevada RECRUITING Las Vegas Nevada 89119 United States Details
Gabrail Cancer Center Research RECRUITING Canton Ohio 44718 United States Details
Fujian Cancer Hospital (Department of Hepatobiliary and Pancreatic Oncology /Phase I Ward) RECRUITING FuZhou China Details
Harbin Medical University Cancer Hospital (Gastroenterology Department 2nd Ward) RECRUITING Haerbin China Details
Zhongshan Hospital of Fudan University (Hepatological Surgery Department) RECRUITING Shanghai China Details
Zhongshan Hospital of Fudan University (Medical Oncology Department) RECRUITING Shanghai China Details
Liaoning Cancer Hospital (Phase I Ward) RECRUITING Shenyang China Details
Yantai Yuhuangding Hospital (Department of Medical Oncology, 1) RECRUITING Yantai China Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field